Annual report pursuant to Section 13 and 15(d)

9. STOCK OPTIONS (Tables)

v2.4.1.9
9. STOCK OPTIONS (Tables)
12 Months Ended
Dec. 31, 2014
Equity [Abstract]  
Schedule of stock options outstanding
   

Year Ended

December 31, 2014

   

 Year Ended

December 31, 2013

 
          Weighted           Weighted  
          Average           Average  
          Exercise           Exercise  
    Shares     Price     Shares     Price  
                         
Outstanding at beginning of year     826,995     $ 6.90       749,211     $ 6.86  
                                 
Forfeited     -       -       (6,350)   $ 7.56  
Granted     221,932     $ 8.50       84,134     $ 7.56  
Outstanding at end of year and expected to vest     1,048,927     $ 7.24       826,995     $ 6.90  
Options exercisable     635,763     $ 6.81       391,822     $ 6.23  
                                 
Weighted average fair value of options                                
granted during the year           $ 5.06             $ 4.35  

Stock-based compensation expense
    2014     2013  
             
Research and development   $ 541,140     $ 227,085  
Plasma centers     56,900       -  
General and administrative     650,414       661,210  
Total stock-based compensation expense   $ 1,248,454     $ 888,295